Welcome to the e-CCO Library!

N20: Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Sider*1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, R. Buckingham1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N20: Safety of extended blood monitoring for adult Inflammatory Bowel Disease (IBD) patients on oral azathioprine during the COVID-19 pandemic: a single-centre audit
Year: 2022
Source: ECCO'22
Authors: AL-HASANI, A.(1);Younge, L.(1);Chana, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
N20: The added shame of IBD: experiences of people from various ethnic backgrounds discussing sexual wellbeing in clinical settings.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fourie, S.(1)*;Czuber-Dochan, W.(2);Norton, C.(2);
Created: Friday, 14 July 2023, 10:43 AM
N21 Self-management and healthcare utilisation of 16–21 year olds with inflammatory bowel disease (IBD) attending one Irish hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Forry, M. Milewska, C. Lardner, T. Lukose, N. Godwin, K. Boland, S. Patchett, A. O’Toole

Created: Thursday, 30 January 2020, 10:12 AM
N21: Patient education is (sometimes) better than cure.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Müskens, B.(1)*;
Created: Friday, 14 July 2023, 10:43 AM
N21: The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Campbell*1, E. Nelson2, S. Kari2, J. Hocking3, T. Hickey3

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N22 Nurse led therapeutic drug monitoring (TDM) of Infliximab in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Gleeson1, K. Sugrue2, M. Buckley2, J. McCarthy2

Created: Thursday, 30 January 2020, 10:12 AM
N22: Audit into initial response to vedolizumab infusions for IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Lloyd-Ford*1, M. Gordon1

Created: Friday, 22 February 2019, 9:41 AM
N22: Inflammatory bowel disease nursing in Italy: the experience of the Academic Hospital of Udine.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Povoli, A.(1);Simonetta, G.(1);D'Agaro, P.(1);Marangone, S.(1);Marino, M.(1)*;Berretti, D.(1);
Created: Friday, 14 July 2023, 10:43 AM
N23 Concerns of patients with inflammatory bowel disease in the process of disease management
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S.M. Mohsenizadeh1, Z.S. Manzari2, H. vosoghinia3, H. Ebrahimipour4

Created: Thursday, 30 January 2020, 10:12 AM
N23: Burnout among European IBD specialists – a survey supported by ECCO
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sánta, A.(1)*;Volosin, M.(2);Farkas, K.(1);Keresztes, C.(3);Rafael , B.(4);Molnár, T.(1);
Created: Friday, 14 July 2023, 10:43 AM
N23: IBD patients experience of the care given at the Stockholm Gastro Centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Jäghult*1,2, S. Soto Villagran2, S. Pengel2, L. Niculae2

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N24 Prioritised adolescent healthcare transition readiness factors by Canadian inflammatory bowel disease nurses
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Rohatinsky1, T. Risling1, M. Kumaran2, L.A. Hellsten3

Created: Thursday, 30 January 2020, 10:12 AM
N24: At Home Calprotectin a United Kingdom Patient Perspectives and Tertiary Center Experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Avery, P.(1)*;Adio, J.(1);Cornford, R.(2);Younge, L.(1);
Created: Friday, 14 July 2023, 10:43 AM
N24: Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Buckingham*1, S. Sider1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM
Files: 1
N25 Outcomes of a GP outreach programme to offer colonoscopic surveillance for IBD patients being managed in primary care
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Windak, V. Cairnes, N. Chanchlani, C. Desmond, B. Hamilton, N. Heerasing, P. Hendy, L. Simeng, N.A. Kennedy, J. Goodhand, T. Ahmad, C. Gordon

Created: Thursday, 30 January 2020, 10:12 AM
N25: Diagnostic delay and economic burden in ibd: a multicenter italian experience in patients treated with biologics
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mocci, G.(1);Onidi, F.M.(1)*;Magri', S.(2);Bodini, G.(3);Lorenzetti, R.(4);Binaghi, L.(1);Dore, M.F.(1);Martello , S.(1);Usai Satta, P.(1);Elisei, W.(5);Tursi, A.(6);
Created: Friday, 14 July 2023, 10:43 AM
N26 Experiences of patients with inflammatory bowel disease (IBD) regarding faecal incontinence and the guidance received
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T.T.I. Toivonen1, K. Helin2, R. Nikkola3

Created: Thursday, 30 January 2020, 10:12 AM
N26: Help-seeking experiences of patients with Inflammatory Bowel Disease from healthcare professionals: A qualitative descriptive study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Byron, C.(1,2)*;Lehane, E.(2);Burton, A.(2);Cornally , N.(2);
Created: Friday, 14 July 2023, 10:43 AM
N27 What people want! Exploring inflammatory bowel disease patients’ perspectives on healthcare professionals addressing sexual well-being
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Fourie1, W. Czuber-Dochan2, C. Norton2

Created: Thursday, 30 January 2020, 10:12 AM